Compounds > n(8)-bromoacetyl-n(1)-3'-(4-indolyloxy)-2'-hydroxypropyl-1,8-diamino-4-menthane

n(8)-bromoacetyl-n(1)-3'-(4-indolyloxy)-2'-hydroxypropyl-1,8-diamino-4-menthane and alprostadil

n(8)-bromoacetyl-n(1)-3'-(4-indolyloxy)-2'-hydroxypropyl-1,8-diamino-4-menthane has been researched along with alprostadil in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Insel, PA; Jasper, JR; Motulsky, HJ1

Other Studies

1 other study(ies) available for n(8)-bromoacetyl-n(1)-3'-(4-indolyloxy)-2'-hydroxypropyl-1,8-diamino-4-menthane and alprostadil

ArticleYear
Characterization of a bromoacetylated derivative of pindolol as a high affinity, irreversible beta adrenergic antagonist in cultured cells.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 244, Issue:3

    Topics: Adrenergic beta-Antagonists; Alprenolol; Alprostadil; Animals; Cyclic AMP; Cyclohexane Monoterpenes; Dose-Response Relationship, Drug; Iodocyanopindolol; Membrane Proteins; Mice; Pindolol; Receptors, Adrenergic, beta; Tumor Cells, Cultured

1988